Balentine LLC’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-11,047
| Closed | -$88K | – | 651 |
|
|
2021
Q4 | $88K | Buy |
+11,047
| New | +$88K | ﹤0.01% | 368 |
|
|
2020
Q3 | – | Sell |
-386
| Closed | -$5K | – | 775 |
|
|
2020
Q2 | $5K | Buy |
+386
| New | +$5K | ﹤0.01% | 744 |
|
|
2019
Q4 | – | Sell |
-262
| Closed | -$2K | – | 748 |
|
|
2019
Q3 | $2K | Buy |
262
+37
| +16% | +$282 | ﹤0.01% | 648 |
|
|
2019
Q2 | $2K | Sell |
225
-480
| -68% | -$4.27K | ﹤0.01% | 651 |
|
|
2019
Q1 | $11K | Buy |
+705
| New | +$11K | ﹤0.01% | 259 |
|
|
2018
Q4 | – | Sell |
-1,761
| Closed | -$38K | – | 479 |
|
|
2018
Q3 | $38K | Buy |
+1,761
| New | +$38K | ﹤0.01% | 90 |
|
|
2017
Q4 | – | Sell |
-268
| Closed | -$5K | – | 662 |
|
|
2017
Q3 | $5K | Buy |
268
+2
| +0.8% | +$37 | ﹤0.01% | 521 |
|
|
2017
Q2 | $9K | Buy |
266
+2
| +0.8% | +$68 | ﹤0.01% | 453 |
|
|
2017
Q1 | $8K | Sell |
264
-73
| -22% | -$2.21K | ﹤0.01% | 436 |
|
|
2016
Q4 | $12K | Buy |
337
+77
| +30% | +$2.74K | ﹤0.01% | 387 |
|
|
2016
Q3 | $12K | Buy |
260
+1
| +0.4% | +$46 | ﹤0.01% | 339 |
|
|
2016
Q2 | $13K | Buy |
259
+2
| +0.8% | +$100 | ﹤0.01% | 310 |
|
|
2016
Q1 | $14K | Buy |
257
+1
| +0.4% | +$54 | ﹤0.01% | 215 |
|
|
2015
Q4 | $17K | Sell |
256
-722
| -74% | -$47.9K | ﹤0.01% | 267 |
|
|
2015
Q3 | $55K | Sell |
978
-72
| -7% | -$4.05K | 0.01% | 155 |
|
|
2015
Q2 | $62K | Buy |
1,050
+1
| +0.1% | +$59 | 0.01% | 132 |
|
|
2015
Q1 | $65K | Buy |
+1,049
| New | +$65K | 0.01% | 117 |
|